Four-year use of SGLT2i as adjunctive therapy in adults with type 1 diabetes: a real-world experience

Scritto il 28/02/2025
da Marina Valenzano

No abstract

Acta Diabetol. 2025 Feb 28. doi: 10.1007/s00592-025-02474-7. Online ahead of print.

NO ABSTRACT

PMID:40019591 | DOI:10.1007/s00592-025-02474-7